Pharmadox Healthcare Limited Pharmaceutical Import Profile — Malta (DGFT 2022–2026)

Name: Pharmadox Healthcare Limited Pharmaceutical Import Records from India — 6 Products, $7.6M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Pharmadox Healthcare Limited — Pharmaceutical Importer Profile (2026) | 6 Products, $7.6M Trade | TransData Nexus

Pharmadox Healthcare Limited

Pharmaceutical Importer · Malta · Cardiovascular Focus · $7.6M Total Trade · DGFT Verified

Pharmadox Healthcare Limited is a pharmaceutical importer based in Malta with a total trade value of $7.6M across 6 products in 4 therapeutic categories. Based on 344 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Pharmadox Healthcare Limited sources from 18 verified Indian suppliers, with Msn Laboratories Private Limited accounting for 45.8% of imports.

Pharmadox Healthcare Limited — Import Portfolio & Supplier Network

Pharmadox Healthcare Limited import network — 6 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Pharmadox Healthcare Limited?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Msn Laboratories Private Limited	$4.1M	321	45.8%
Zentiva Private Limited	$1.7M	70	18.8%
Micro Labs Limited

What Formulations Does Pharmadox Healthcare Limited Import?

Formulation	Value	Ships
Amoxicilline evolugen 1g amoxicillin	$385.3K	11
Msn pharma dabigatran etex m cap 150MG 60c	$184.8K	6
Pharmaceutical products - rivaroxaban ztv 20MG tabco bl2x14 m24 fr (51772 pcs	$152.7K	6
Diclofenac viatris l.p 75MG (diclofenacsodium 75MG prolonged release film coated tablets,Pack 3x10`s,qty	$150.0K	3
Pharamaceutical products xanirva 20MG tabco bl7x14 m24 cz zmid code	$150.0K	3
Diclofenac viatris l.p. 75 MG (diclofenac sodium 75MG prolonged release filmcoated tablets) ( 3x10s	$146.1K	3
Pharamaceutical products rivaroxaban 20MG tabco bl7x14 m24 de zmid code	$141.4K	3
Ranolazine celix 750MG ranolazine 750MG	$131.7K	3
Pharmaceutical article / ods / product / item - xanirva 20MG	$119.7K	3
Pregabalin capsules 150MG x 100	$110.6K	6
Dabigatran etex mesy cap 150MG 60cse/fibatach no:drd09507bmsn	$100.0K	2
Dabigatran etexi mesyl cap 150MG 60cnlbatach no:drd09372amsn	$100.0K	2
Dabigatran etex m cap 150MG 60cdk/no/isbatch no:drd09117amsn	$81.4K	3
Pharmaceutical article / ods / product / item - xanirva 15MG	$81.2K	4
Pharamaceutical products rivaroxaban ztv 20MG tabco bl2x14 m24 pt zmid code	$73.3K	3

Pharmadox Healthcare Limited imports 923 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 6 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Rivaroxaban	Cardiovascular	$5.0M	244	7.5%	2
2	Apixaban	Cardiovascular	$1.6M	32	0.9%	17
3	Cabazitaxel	Advanced Oncology	$423.0K	44	2.9%	8
4	Acetylsalicylic	Combination Drugs	$249.4K	11	5.7%	5
5	Salicylic	Combination Drugs	$249.4K	11	1.5%	10
6	Vati	Ayurvedic & Herbal Products	$100.0K	2	0.4%	11

Pharmadox Healthcare Limited imports 6 pharmaceutical products across 4 categories into Malta totaling $7.6M.

Pharmadox Healthcare Limited — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Pharmadox Healthcare Limited is a prominent pharmaceutical company based in Malta, specializing in the development, importation, and distribution of pharmaceutical products. Established in 2006, the company has grown to become a key player in the Maltese pharmaceutical sector, offering a comprehensive range of services to meet the evolving needs of its clients.

Headquartered at KW20A, Kordin Industrial Park, Paola, PLA 3000, Malta, Pharmadox Healthcare Limited operates state-of-the-art facilities that adhere to the highest industry standards. The company's strategic location in Malta enables it to efficiently serve both local and international markets, ensuring timely and professional service delivery to its valued B2B clients.

2Distribution Network

Pharmadox Healthcare Limited's distribution network is strategically designed to ensure efficient delivery of pharmaceutical products across Malta and beyond. The company's facilities in Paola, Malta, serve as central hubs for warehousing and logistics operations. While specific details about additional warehouse locations are not publicly disclosed, the company's infrastructure is equipped to handle a diverse range of pharmaceutical products, ensuring compliance with local and EU regulations.

3Industry Role

In Malta's pharmaceutical supply chain, Pharmadox Healthcare Limited functions primarily as a pharmaceutical importer and distributor. The company sources a wide array of pharmaceutical products from various international suppliers, including a significant volume from India, and ensures their availability in the Maltese market. By managing the importation and distribution processes, Pharmadox Healthcare Limited plays a crucial role in maintaining the supply of essential medicines to healthcare providers and patients across Malta.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Pharmadox Healthcare Limited

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Pharmadox Healthcare Limited's sourcing strategy exhibits a notable concentration on a select group of suppliers, particularly from India. The company's total import value from India amounts to $7.6 million USD, distributed across 344 shipments. The top five products imported from India include Rivaroxaban ($5.0 million, 7.5% share), Apixaban ($1.6 million, 0.9% share), Cabazitaxel ($423,000, 2.9% share), Acetylsalicylic ($249,000, 5.7% share), and Salicylic ($249,000, 1.5% share). These five products collectively account for 98.7% of the total import value, indicating a high level of portfolio concentration.

The reliance on a limited number of products and suppliers suggests that Pharmadox Healthcare Limited's sourcing strategy may be driven by strategic partnerships and favorable terms with these suppliers. However, this concentration also introduces potential risks, such as supply chain disruptions or price fluctuations. The company's extensive number of shipments (344) from 18 unique Indian suppliers indicates a diversified supplier base, which may help mitigate some of these risks.

2Supply Chain Resilience

Pharmadox Healthcare Limited's supply chain resilience is supported by its diversified supplier base, encompassing 18 unique Indian suppliers. This diversification reduces dependency on a single supplier and enhances the company's ability to adapt to potential disruptions. The company's importation of 923 unique pharmaceutical formulations further demonstrates its capacity to source a wide range of products, catering to various therapeutic needs.

Importing Pharmaceuticals into Malta — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Malta

1Regulatory Authority & Framework

In Malta, the Medicines Authority is the primary regulatory body overseeing the pharmaceutical sector. The authority is responsible for ensuring that medicinal products meet the required quality, safety, and efficacy standards before they are authorized for sale in the Maltese market. This includes the evaluation and approval of marketing authorizations for medicinal products, as well as the monitoring of their post-market performance. (medicinesauthority.gov.mt)

Key legislation governing pharmaceutical imports into Malta includes the Medicines Act, 2003, and the Good Manufacturing Practice (GMP) regulations. The Medicines Act provides the legal framework for the regulation of medicinal products, while the GMP regulations set out the standards for manufacturing processes to ensure product quality. Indian generics seeking marketing authorization in Malta must comply with these regulations, demonstrating that their products meet the necessary quality standards and are manufactured in accordance with GMP guidelines. (medicinesauthority.gov.mt)

2Import Licensing & GMP

Import licensing is a critical component of Malta's pharmaceutical regulatory framework. Under the Importation Control Regulations (Legal Notice 242 of 2004), certain goods, including pharmaceuticals, require an import license issued by the Trade Services and Projects Directorate, Commerce Department. This license ensures that imported medicinal products comply with Maltese regulations and are authorized for sale in the market. (commerce.gov.mt)

Pharmadox Healthcare Limited — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Pharmadox Healthcare Limited's product strategy focuses on key therapeutic areas, including cardiovascular, combination drugs, and advanced oncology. The company's significant importation of Rivaroxaban and Apixaban, both anticoagulants, indicates a strong emphasis on cardiovascular health. The inclusion of Cabazitaxel highlights a commitment to advanced oncology treatments. This strategic focus aligns with market demand for effective therapies in these critical areas, addressing the healthcare needs of the Maltese population.

2Sourcing Profile

Pharmadox Healthcare Limited's sourcing strategy is centered on generic drugs, primarily imported from India. The company's preference for finished pharmaceutical formulations, such as tablets, capsules, syrups, and injections, reflects a focus on ready-to-market products that meet the therapeutic needs of patients. India's well-established pharmaceutical manufacturing sector, known for its compliance with international quality standards, makes it a preferred sourcing destination for Pharmadox Healthcare Limited.

3Market Positioning

Based on its product mix, Pharmadox Healthcare Limited serves multiple segments of the Maltese pharmaceutical market. The company's focus on cardiovascular and oncology products positions it to supply both retail pharmacies and hospital pharmacies with essential medications. Additionally, the company's importation of combination drugs suggests involvement in government tenders, providing cost-effective treatment options to the public healthcare system.

Seller's Guide — How to Become a Supplier to Pharmadox Healthcare Limited

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to engage with Pharmadox Healthcare Limited. The company's diversified supplier base and extensive product portfolio indicate a willingness to explore new partnerships. Potential gaps in Pharmadox Healthcare Limited's current sourcing include emerging therapeutic areas or specialized formulations not currently represented in its product mix. Indian exporters can leverage these opportunities by offering innovative products that align with the company's strategic focus and market demand.

2Requirements & Qualifications

Indian exporters seeking to supply Pharmadox Healthcare Limited and the Maltese market must ensure compliance with EU Good Manufacturing Practice (GMP) standards. Products must be authorized for sale in Malta, with appropriate marketing authorizations obtained from the Medicines Authority. Additionally, exporters should provide Certificates of Pharmaceutical

TransData Nexus Research · Industry procurement practicesMar 2026

Frequently Asked Questions — Pharmadox Healthcare Limited

What products does Pharmadox Healthcare Limited import from India?

Pharmadox Healthcare Limited imports 6 pharmaceutical products across 4 categories. Top imports: Rivaroxaban ($5.0M), Apixaban ($1.6M), Cabazitaxel ($423.0K), Acetylsalicylic ($249.4K), Salicylic ($249.4K).

Who supplies pharmaceuticals to Pharmadox Healthcare Limited from India?

Pharmadox Healthcare Limited sources from 18 verified Indian suppliers. The primary supplier is Msn Laboratories Private Limited (45.8% of imports, $4.1M).

What is Pharmadox Healthcare Limited's total pharmaceutical import value?

Pharmadox Healthcare Limited's total pharmaceutical import value from India is $7.6M, based on 344 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Pharmadox Healthcare Limited focus on?

Pharmadox Healthcare Limited imports across 4 categories. The largest: Cardiovascular (86.5%), Combination Drugs (6.6%), Advanced Oncology (5.6%).

Get Full Pharmadox Healthcare Limited Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 3 company name variants from customs records. For current shipment-level data, contact TransData Nexus.